New nanotechnological therapy for Parkinson´s disease: nose to brain delivery of GBA-polymer nanoconjugates

Project Details

Description

Nanoconjugation of recombinant GBA as a new therapy in Parkinson’s
disease to restore neuronal GBA activity
AcronymNANOGBAtoBRAIN
StatusActive
Effective start/end date1/01/2231/12/24

Collaborative partners

  • (lead)
  • Universitat Autònoma de Barcelona (UAB)
  • Centro de Investigación Príncipe Felipe-Fundación Valenciana de Investigaciones Biomédicas

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.